Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · IMMUNIC, INC. (IMUX)

Immunic to host RMS R&D Day webinar on September 9, 2026 with presentation

Neutral Impact 2 of 5 other Written later

Immunic, Inc. is hosting a Relapsing Multiple Sclerosis (RMS) Research and Development Day webinar on September 9, 2026, from 11:00 a.m. to 12:30 p.m. ET, and has filed a presentation for the event as Exhibit 99.1. The filing contains no financial results, guidance, or new clinical data beyond the presentation itself, so the event is routine for shareholders.

Key points

  • RMS R&D Day webinar held September 9, 2026, 11:00 a.m. to 12:30 p.m. ET by video conference
  • Company presentation dated September 9, 2026 furnished as Exhibit 99.1
  • Filing is furnished under Regulation FD and not deemed filed under Section 18 of the Exchange Act

The filing

CompanyIMMUNIC, INC. (IMUX)
Form8-K, current report
Filed with the SECSep 9, 2026, 9:01 AM ET
Accession number0001193805-26-001196

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 09, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.